Avid Bioservices

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

Avid’s mission is to help biopharmaceutical companies bring complex and innovative therapies to market by providing specialized process development and cGMP manufacturing services for clinical and commercial supply.

To be the leader in specialized process development and cGMP manufacturing of biopharmaceuticals to the global biopharmaceutical companies.

Avid has received numerous awards, including the 2018 Golden Bridge Business Award from Silicon Valley, which recognizes industry leaders and their commitment to innovation and enterprise achievement. Avid was also honored as one of NACD’s 2018 Top 20 Public Biotech Companies, which recognizes the industry’s best-performing companies in terms of market capitalization and revenue growth.